Skip to content
MSCopilot
I am a Healthcare ProfessionalI am a PatientScientific References
Login Pro
I am a Healthcare ProfessionalI am a PatientScientific ReferencesLogin Pro

MSCopilot®: the first clinically validated medical device12 for monitoring the progression of multiple sclerosis.

Reinventing MS monitoring

Healthcare Professional

Discover the healthcare professional portal

Healthcare Professional Portal

Patient

Discover the MSCopilot® app

MSCopilot® Application
MSCopilot interface — clinical dashboard and mobile app

What makes MSCopilot® unique

MSCopilot® was born from a simple observation: Multiple Sclerosis (MS) continues to progress between appointments

For truly relevant monitoring, it is essential to measure symptoms in patients’ daily lives, not only during medical appointments.

For you, Patients

Turn your smartphone into a truly clinically validated monitoring tool. Perform tests inspired by clinical evaluation scales wherever you are, whenever you want, and become an active participant in your care.12

Patient using MSCopilot
Healthcare professional with MSCopilot

For you, Healthcare Professionals

Access objective, structured and actionable data to support clinical decision-making.

For you, Patients

Turn your smartphone into a truly clinically validated monitoring tool. Perform tests inspired by clinical evaluation scales wherever you are, whenever you want, and become an active participant in your care.12

Patient using MSCopilot

For you, Healthcare Professionals

Access objective, structured and actionable data to support clinical decision-making.

Healthcare professional with MSCopilot

A solution co-designed with you

Because no one understands MS better than those who treat it and those who live with it, MSCopilot® is the result of a unique collaboration.

Shared expertise

An alliance between Ad Scientiam’s digital health expertise, MS specialist neurologists, and patients, to ensure a tool adapted to the real needs of its users.

Medical team co-designing MSCopilot
Data security

A certified and secure solution

CE Marking

CE-Marked & FDA-Listed Medical Device

MSCopilot® is not just a health app. It is a Class IIa Medical Device CE marked under Regulation (EU) 2017/745, and a Class II device listed with the U.S. Food and Drug Administration (FDA), recognized for its safety and clinical benefit.

Clinical studies

Scientific Credibility & Clinical Studies

MSCopilot® is the result of 10 years of research and development, conducted in collaboration with clinical research teams specialized in MS. The solution has been continuously tested, improved and validated through various clinical studies12, ensuring its reliability and medical relevance.

Data protection

Data Protection (HIPAA)

Data collected by MSCopilot® is hosted on secure, HIPAA-compliant servers. Patients can choose to share their data with the healthcare professionals of their choice and can revoke sharing at any time.

View all scientific references
MSCopilot
CE

MSCopilot (DA100) is a class IIa digital medical device in the European Union, manufactured by Ad Scientiam in accordance with Regulation (EU) 2017/745. The device is CE marked based on a conformity assessment carried out by the notified body Kiwa Cermet Italia (CE 0476), applying from version 2.0 onwards.

In the United States, MSCopilot (DA100) is a class II digital medical device developed by Ad Scientiam, listed with the Food and Drug Administration (FDA) and commercialized in accordance with applicable regulatory requirements. The device is exempt from premarket notification requirements (510(k)).

FacebookLinkedInInstagram

Menu

  • Healthcare Professional
  • Patient

Legal

  • Legal Notice
  • Privacy Policy – Website

Help

  • Terms of Use
  • Privacy Policy
  • Instructions for Use
  • FAQ
  • Scientific References

Get in touch

Download the app

Download on the App StoreGet it on Google Play
Developed byAd Scientiam

MSCopilot® must be used only in accordance with its intended purpose, under the conditions and versions specified by the manufacturer, and in accordance with the applicable instructions for use. Do not use the device outside the indications, limitations, contraindications or technical conditions specified in the instructions or labeling.

Read the instructions for use carefully before use.  If in doubt about the use of the device, the results provided or your state of health, ask your doctor or any other qualified healthcare professional for advice. This device does not replace medical advice.

In accordance with applicable regulatory requirements, any serious incident, adverse effect or complaint related to the use of MSCopilot must be reported without delay to Ad Scientiam at the following address:

  • - For patients using the Application: contact@mscopilot.com
  • - For healthcare professionals using the Dashboard: contact.pro@mscopilot.com

Ad Scientiam, SAS au capital de 673 770 €, sis au 38 rue Dunois 75647 Paris CEDEX 13 France, RCS PARIS 795 083 336 All rights reserved | Website version 1.1.3 – updated on